BANK OF AMERICA CORP /DE/ - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 79 filers reported holding CYTOSORBENTS CORP in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$127,678
-47.4%
67,914
+0.4%
0.00%
Q2 2023$242,771
+4.2%
67,624
-2.2%
0.00%
Q1 2023$233,089
+103.7%
69,166
-6.3%
0.00%
Q4 2022$114,421
+3.1%
73,820
-9.4%
0.00%
Q3 2022$111,000
-54.5%
81,480
-26.8%
0.00%
Q2 2022$244,000
+79.4%
111,238
+161.2%
0.00%
Q1 2022$136,000
-46.0%
42,586
-29.3%
0.00%
Q4 2021$252,000
-48.5%
60,264
+0.1%
0.00%
Q3 2021$489,000
+5.8%
60,232
-1.6%
0.00%
Q2 2021$462,000
-38.4%
61,224
-29.1%
0.00%
Q1 2021$750,000
+27.6%
86,309
+17.0%
0.00%
Q4 2020$588,000
+17.1%
73,765
+17.2%
0.00%
Q3 2020$502,000
-22.5%
62,934
-3.8%
0.00%
Q2 2020$648,000
+44.3%
65,433
+12.7%
0.00%
Q1 2020$449,000
+106.9%
58,073
+2.8%
0.00%
Q4 2019$217,000
-28.4%
56,469
-6.1%
0.00%
Q3 2019$303,000
-40.7%
60,169
-22.2%
0.00%
Q2 2019$511,000
-1.9%
77,387
+12.4%
0.00%
Q1 2019$521,000
-22.8%
68,848
-17.5%
0.00%
Q4 2018$675,000
+42.7%
83,489
+127.8%
0.00%
Q3 2018$473,000
+19.7%
36,649
+5.9%
0.00%
Q2 2018$395,000
+77.9%
34,597
+10.0%
0.00%
Q1 2018$222,000
+572.7%
31,463
+529.3%
0.00%
Q4 2017$33,000
+3200.0%
5,000
+2400.0%
0.00%
Q2 2017$1,000200
+344.4%
0.00%
Q1 2017$0
-100.0%
45
-99.3%
0.00%
Q2 2016$29,000
+2800.0%
6,540
+6642.3%
0.00%
Q2 2015$1,000
-87.5%
97
-87.9%
0.00%
Q4 2014$8,0008000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders